Companies: 10,795·Total market cap: $144.5T
Femasys Inc.

Femasys Inc.

FEMYNASDAQHealthcare● Active
$5.32
$-0.08(-1.39%)
Market Cap$18702209
P/E Ratio—
52W High$22.2
52W Low$5.09
Overview

Femasys Inc. (FEMY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001339005 · FEMY · NASDAQ · as of Jun 9, 2026

Filing snapshot

314
Total Filings
8-K
Latest Form
2026-06-05
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001339005 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-31
Fiscal Year End
Mar 31, 2026
Accession No.
0001140361-26-012375
Primary Document
femy-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001339005 · Accession 0001140361-26-012375

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-08
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-05
View
8-KCurrent Report
8-K
2026-06-04
View
8-KCurrent Report
8-K
2026-05-13
View
10-QQuarterly Report
10-Q
2026-05-08
View
8-KCurrent Report
8-K
2026-05-08
View
DEF 14AProxy Statement
DEF 14A
2026-04-30
View
ARSARS
ARS
2026-04-30
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-30
View
8-KCurrent Report
8-K
2026-04-29
View
DEF 14AProxy Statement
DEF 14A
2026-04-06
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-04-01
View
8-KCurrent Report
8-K
2026-04-01
View
S-8Employee Stock Plan Registration
S-8
2026-03-31
View
10-KAnnual Report
10-K
2026-03-31
View
8-KCurrent Report
8-K
2026-03-31
View
Showing 1–15 of 249 filingsForm 4 / 144 hidden· 314 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001339005  |  Exchange: NASDAQ · Healthcare

Femasys Inc. (NASDAQ: FEMY) has submitted 314 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001339005, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Femasys Inc.'s most comprehensive regulatory disclosure. The most recent Femasys Inc. 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical FEMY 10-K annual reports are available from 2005 through 2026.

Investors researching Femasys Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
EKSO SEC Filings →HBIO SEC Filings →DARE SEC Filings →APLM SEC Filings →COCH SEC Filings →AIMD SEC Filings →CRIS SEC Filings →BCTX SEC Filings →
→ FEMY Financials→ FEMY Earnings→ FEMY Insider Trades

Frequently Asked Questions

FEMY SEC Filings · 8 questions

Femasys Inc. (FEMY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 314 filings and access original documents at no cost. Femasys Inc.'s CIK is 0001339005.

FEMY SEC filingsFemasys Inc. SEC documentsfind FEMY 10-K